IRWD

IRONWOOD PHARMACEUTICALS INC

Biotechnology · Biotechnology

$104.03 sample

+1.58 (+1.54%) 1D

Market cap

$189.4B

Price as of

2026-10-15

Latest filing

8-K

Alerts

8

Price$104.03 -3.97% 3M daily closessample

109.1698.77

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider buy: Chief Executive Officer
Oct 02INSInsider sell: Chief Financial Officer
Sep 29INSInsider buy: Director
Sep 18INSInsider sell: 10% owner
Sep 09INSInsider sell: 10% owner
Aug 31INSInsider buy: Director
Aug 25INSInsider buy: Chief Executive Officer
Aug 18INSInsider buy: Director

Sign up to see the real IRWD record →

Company facts

SEC EDGAR registration

Name: IRONWOOD PHARMACEUTICALS INC
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +4sample, -100 to +100
Reporting currency: USD

Who is positioning in IRWD

sample

Insiders: 31 insider transactions over 90 days, net selling, $746.9M
Congress: No member trades over 90 days
Institutions · 13F: 24 funds hold $3.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$12.7B +15.5% y/y

Q4 2024Q3 2026

Inventory$7.4B +10.2% y/y

Q4 2024Q3 2026

Accounts receivable$5.7B +15.0% y/y

Q4 2024Q3 2026

Total debt$14.5B +7.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $174.9B -1.9% 3M
Sample peer B: $183.0B -5.8% 3M
Sample peer C: $96.2B -11.7% 3M
Sample peer D: $137.8B -7.5% 3M
Sample peer E: $73.4B -13.2% 3M